Results 71 to 80 of about 35,087 (150)

CORONAVIRUS DISEASE 2019 (COVID-19)

Journal of University Medical & Dental College, 2020
The epidemic of 2019 novel coronavirus (2019-nCoV) has been emerged from a major city named Wuhan in the Hubei Province of China. It appears to have the potential to cause a major health problem globally. Earlier it is called 2019-nCoV but now this virus
Aysha Azhar
doaj   +1 more source

Bioethical Issues as Triggers of Religious Transformation in Orthodox Christianity

Bioethics, Volume 40, Issue 1, Page 45-51, January 2026.
ABSTRACT The advent of new biomedical technologies has given rise to an emerging area of sociocultural discourse. The sociocultural perception of these technologies is contingent upon a number of factors, including the prevailing attitudes within dominant religious traditions. Religious bioethics is fundamentally distinct from secular bioethics.
Roman Tarabrin
wiley   +1 more source

D3Targets-2019-nCoV: A Web Server to Identify Potential Targets for Antivirals Against 2019-nCoV [PDF]

, 2020
2019-nCoV has caused more than 560 deaths as of 6 February 2020 worldwide, mostly in China. Although there are no effective drugs approved, many clinical trials are incoming or ongoing in China which utilize traditional chinese medicine or modern medicine.
Yulong Shi, Xinben Zhang, Kaijie Mu, Cheng Peng, Zhengdan Zhu, Xiaoyu Wang, Yanqing Yang, Zhijian Xu, weiliang zhu   +8 more
openaire   +1 more source

Association between stress hyperglycemia ratio and prognosis of patients hospitalized with COVID‐19: A meta‐analysis

Journal of Diabetes Investigation, Volume 17, Issue 1, Page 174-186, January 2026.
This meta‐analysis found that a high stress hyperglycemia ratio (SHR) at admission is significantly associated with an increased risk of poor outcomes, including ICU admission, invasive mechanical ventilation, and in‐hospital mortality, in patients hospitalized with COVID‐19.
Lizhan Chen, Mingming Wang, Jie Chen
wiley   +1 more source

Molecular changes in agroinfiltrated leaves of Nicotiana benthamiana expressing suppressor of silencing P19 and coronavirus‐like particles

Plant Biotechnology Journal, Volume 24, Issue 1, Page 99-130, January 2026.
Summary The production of coronavirus disease 2019 vaccines can be achieved by transient expression of the spike (S) protein of severe acute respiratory syndrome coronavirus 2 in agroinfiltrated leaves of Nicotiana benthamiana. Relying on bacterial vector Agrobacterium tumefaciens, this process is favoured by co‐expression of viral silencing suppressor
Louis‐Philippe Hamel, Francis Poirier‐Gravel, Marie‐Ève Paré, Rachel Tardif, Marc‐André Comeau, Pierre‐Olivier Lavoie, Andréane Langlois, Marie‐Claire Goulet, Dominique Michaud, Marc‐André D'Aoust   +9 more
wiley   +1 more source

Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know

Frontiers in Public Health, 2020
The outbreak of the current 2019 novel coronavirus (2019-nCoV, now named SARS-CoV-2) infection has become a worldwide health threat. Currently, more information is needed so as to further understand the transmission and clinical characteristics of 2019 ...
Chuan-bin Sun, Yue-ye Wang, Geng-hao Liu, Zhe Liu   +3 more
doaj   +1 more source

Pangolin homology associated with 2019-nCoV [PDF]

, 2020
AbstractTo explore potential intermediate host of a novel coronavirus is vital to rapidly control continuous COVID-19 spread. We found genomic and evolutionary evidences of the occurrence of 2019-nCoV-like coronavirus (named as Pangolin-CoV) from dead Malayan Pangolins.
Zhang T, Wu Q, Zhang Z.
europepmc   +2 more sources

Patients Suffering From Post‐COVID‐19 Syndrome Feature Enhanced Antibody Reactivity Towards Specific Linear Epitopes Within EBV EBNA1

Scandinavian Journal of Immunology, Volume 103, Issue 1, January 2026.
Compared to convalescent individuals, post‐COVID‐19 patients showed increased IgG antibody reactivity in plasma to both a specific central region (amino acids 405–419) and glycine–alanine repeat sequences of EBV EBNA1. The sequences of the central region differ from those associated with molecular mimicry in multiple sclerosis patients.
Peter Lorenz, Felix Steinbeck, Florian Fricke, Franz Mai, Wendy Bergmann‐Ewert, Christine Wossidlo, Emil C. Reisinger, Brigitte Müller‐Hilke   +7 more
wiley   +1 more source

Efficacy and Safety of Pirfenidone for Mitigation of Interstitial Lung Abnormalities in COVID‐19 Patients: A Meta‐Analysis

Canadian Respiratory Journal, Volume 2026, Issue 1, 2026.
Background Although post‐COVID‐19 interstitial lung abnormalities (ILAs) are common, the use of antifibrotic agents to prevent their onset and progression is controversial. We aimed to investigate the effectiveness and safety of pirfenidone to mitigate the onset and progression of ILAs in patients with severe COVID‐19.
Ziyi Zhang, Xiang Fang, Jinhui Gao, Heming Sun, Ting Xu, Jiajia Wang, Hongda Liu   +6 more
wiley   +1 more source

Remdesivir in COVID‐19: A Focus on Pediatric Cardiac Patients

Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2026, Issue 1, 2026.
The coronavirus disease 2019 (COVID‐19) pandemic has presented a significant global health challenge that necessitated the immediate search for various therapeutic modalities. Remdesivir, an antiviral drug inhibiting RNA‐dependent RNA polymerase (RdRp), was among the most heavily used drugs against COVID‐19.
Dima Bsat, Dalia Safi, Mariam Arabi, Mamunur Rahman Malik   +3 more
wiley   +1 more source